Owner only: item control page
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylation
Hennig, Robert, Pollinger, Klaus, Veser, Anika, Breunig, Miriam
and Goepferich, Achim
(2014)
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylation.
Journal of Controlled Release 194, pp. 20-27.
Date of publication of this fulltext: 16 Sep 2014 06:16
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Controlled Release | ||||
| Publisher: | ELSEVIER SCIENCE BV | ||||
|---|---|---|---|---|---|
| Place of Publication: | AMSTERDAM | ||||
| Volume: | 194 | ||||
| Page Range: | pp. 20-27 | ||||
| Date | August 2014 | ||||
| Institutions | Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical Technology (Prof. Göpferich) | ||||
| Identification Number |
| ||||
| Keywords | TARGETED DRUG-DELIVERY; QUANTUM DOTS; GOLD NANOPARTICLES; BINDING-AFFINITY; FOLATE RECEPTOR; CANCER-THERAPY; IN-VITRO; CELLS; PHARMACOLOGY; LIPOSOMES; Small molecules; PEGylation; Nanoparticles; Multivalency; Quantum dots; Active targeting | ||||
| Dewey Decimal Classification | 600 Technology > 615 Pharmacy | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 30699 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric